Surgnova

Surgnova

赛诺微医疗

Surgnova

Biotech/Healthcare

Founded in 2015, SinoMicro (Sainuowei) focuses on minimally invasive surgery and tumor interventional therapy. It has built three platforms—surgical visualization, surgical energy, and tumor ablation—and provides overall minimally invasive surgical treatment solutions worldwide.

Latest round: Series C (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-12-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.